Todos Medical Completes Automation Equipment Installation and Training for Meadowlands Diagnostics
· Minority-owned lab now well positioned to attract and expand institutional contracts with skilled nursing facilities, ambulatory surgery centers, schools & first responders
· Automation solution increases processing capacity to 6,000 PCR tests per day, expandable to 12,000 daily tests with minor upgrades
· Todos expects to see a progressive increase in sales to this client in the second half of 2021 through exclusive PCR supply agreement
NEW YORK, NY, and REHOVAT, ISRAEL, April 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening, diagnosis and immune support, as well as developing blood tests for early detection of cancer and Alzheimer’s disease, today announced the successful installation of automated lab equipment and completion of training for Wood-Ridge, NJ-based lab client Meadowlands Diagnostics (“Meadowlands Diagnostics”).
“With the completion of automation at Meadowlands Diagnostics, we have brought two new client labs online in March and now have three fully automated laboratory clients in operation, with a fourth on the way,” said Gerald E. Commissiong, President & CEO of Todos Medical. “We have received their initial sales orders for stocking COVID testing supplies in February and expect to see sales orders from these new labs progressively increase in the second half of 2021 as they ramp up operations. Furthermore, we believe our growing family of lab clients will provide Todos with a more diversified revenue base and greater future sales potential. As the Todos solution continues to gain traction in the space, we are confident that our future growth in this business will be fueled by adding additional laboratories seeking a cost-effective way to meet the needs of COVID testing customers in the markets they service. We are excited to welcome the team at Meadowlands Diagnostics to the Todos family and look forward to helping them build their business as a trusted partner for years to come.”
The Todos automation solution is expected to be instrumental in helping Meadowlands Diagnostics with new contracts entered into with skilled nursing facilities, ambulatory surgery centers, local schools and first responders. As the provider of PCR testing supplies to Meadowlands Diagnostics, Todos expects to see a progressive increase in sales to this client in the second half of 2021 and into 2022 as the lab seeks to grow its PCR testing business.
By implementing the Todos automation solution, Meadowlands Diagnostics now has a capacity of 6,000 PCR tests per day, with the potential to quickly expand to up to 12,000 PCR tests per day. Additionally, the lab could potentially increase processing capacity to in excess of 40,000 PCR tests per day through the future implementation of pooling at a 4:1 ratio.
A video of Todos’ automated PCR solutions is available here: https://vimeo.com/529139115/9d3166bcc0
“When we opened Meadowlands Diagnostics at the beginning of the pandemic, we quickly realized that we were unable to meet the needs of the community,” said Reginald Samuels, President & CEO of Meadowlands Diagnostics. “Now that we’ve partnered with Todos Medical, we have the capacity we need to be able to serve the needs of our community.”
For information related to Todos Medical’s COVID-19 testing capabilities, please visit www.todoscovid19.com.
https://investor.todosmedical.com/news-events...stallation
· Minority-owned lab now well positioned to attract and expand institutional contracts with skilled nursing facilities, ambulatory surgery centers, schools & first responders
· Automation solution increases processing capacity to 6,000 PCR tests per day, expandable to 12,000 daily tests with minor upgrades
· Todos expects to see a progressive increase in sales to this client in the second half of 2021 through exclusive PCR supply agreement
NEW YORK, NY, and REHOVAT, ISRAEL, April 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening, diagnosis and immune support, as well as developing blood tests for early detection of cancer and Alzheimer’s disease, today announced the successful installation of automated lab equipment and completion of training for Wood-Ridge, NJ-based lab client Meadowlands Diagnostics (“Meadowlands Diagnostics”).
“With the completion of automation at Meadowlands Diagnostics, we have brought two new client labs online in March and now have three fully automated laboratory clients in operation, with a fourth on the way,” said Gerald E. Commissiong, President & CEO of Todos Medical. “We have received their initial sales orders for stocking COVID testing supplies in February and expect to see sales orders from these new labs progressively increase in the second half of 2021 as they ramp up operations. Furthermore, we believe our growing family of lab clients will provide Todos with a more diversified revenue base and greater future sales potential. As the Todos solution continues to gain traction in the space, we are confident that our future growth in this business will be fueled by adding additional laboratories seeking a cost-effective way to meet the needs of COVID testing customers in the markets they service. We are excited to welcome the team at Meadowlands Diagnostics to the Todos family and look forward to helping them build their business as a trusted partner for years to come.”
The Todos automation solution is expected to be instrumental in helping Meadowlands Diagnostics with new contracts entered into with skilled nursing facilities, ambulatory surgery centers, local schools and first responders. As the provider of PCR testing supplies to Meadowlands Diagnostics, Todos expects to see a progressive increase in sales to this client in the second half of 2021 and into 2022 as the lab seeks to grow its PCR testing business.
By implementing the Todos automation solution, Meadowlands Diagnostics now has a capacity of 6,000 PCR tests per day, with the potential to quickly expand to up to 12,000 PCR tests per day. Additionally, the lab could potentially increase processing capacity to in excess of 40,000 PCR tests per day through the future implementation of pooling at a 4:1 ratio.
A video of Todos’ automated PCR solutions is available here: https://vimeo.com/529139115/9d3166bcc0
“When we opened Meadowlands Diagnostics at the beginning of the pandemic, we quickly realized that we were unable to meet the needs of the community,” said Reginald Samuels, President & CEO of Meadowlands Diagnostics. “Now that we’ve partnered with Todos Medical, we have the capacity we need to be able to serve the needs of our community.”
For information related to Todos Medical’s COVID-19 testing capabilities, please visit www.todoscovid19.com.
https://investor.todosmedical.com/news-events...stallation
1
